Assembly Biosciences, Inc.

NASDAQ:ASMB

Biotechnology

Healthcare
$22.50 +0.66%

+$0.16 today

Market cap
$460.74M
Beta
1.08
P/E (TTM)
-64.4
EPS (TTM)
-$0.38
52W Low $16.50High $39.71

Volume 0.33M

Average 0.17M

Income Statement

Follow revenue through to earnings.

Revenue

$72.30M

FY 2025 · Annual

+153.5% YoY

Operating Income

-$12.12M

FY 2025 · Annual

Net Income

-$6.12M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue6.25M07.16M28.52M72.3M
Cost of Revenue069.08M48.9M55.93M129K
Gross Profit6.25M(69.08M)(41.74M)(27.41M)72.17M
Gross Margin100.0%—-582.7%-96.1%99.8%
Research & Development68.52M69.98M48.9M55.93M64.81M
Selling, General & Admin28.78M23.93M22.91M18.01M19.61M
Operating Expenses138.94M25.03M22.91M18.01M84.42M
Depreciation & Amortization466K498K450K129K129K
EBITDA(90.58M)(92.52M)(60.75M)(39.72M)(5.99M)
EBITDA Margin-1448.4%—-848.0%-139.3%-8.3%
Operating Income(132.69M)(94.11M)(64.65M)(45.42M)(12.12M)
Operating Margin-2121.7%—-902.5%-159.3%-16.8%
Interest Income302K1.02M3.45M5.57M6M
Interest Expense00000
Other Income / Expenses302K1.02M3.45M5.57M6M
Income Before Tax(132.39M)(93.09M)(61.2M)(39.85M)(6.12M)
Pre-Tax Margin-2116.8%—-854.3%-139.7%-8.5%
Income Tax Expense(2.53M)033K330K0
Net Income(129.86M)(93.09M)(61.23M)(40.18M)(6.12M)
Net Margin-2076.4%—-854.8%-140.9%-8.5%
EPS (Basic)(36.00)(22.82)(13.38)(6.69)(0.55)
EPS (Diluted)(36.00)(22.82)(13.38)(6.69)(0.55)
Weighted Avg Shares3.61M4.03M4.58M6M11.21M
Weighted Avg Shares (Diluted)3.61M4.03M4.58M6M11.21M

ASMB Earnings Waterfall · TTM

NASDAQ:ASMB · Revenue to Net Income

Key Ratios

EPS$-0.58
Gross Margin58.0%
Net Margin-62.4%
P/E Ratio-4.3
P/S Ratio24.7

Analysis

$71.1M of revenue converted into -$6.4M of net income for the selected period. Gross margin is 58.0% and net margin is -62.4%, showing how much revenue survives after costs and taxes. EPS is $-0.58, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
4Statement of changes in beneficial ownershipNov 3, 2026
4Statement of changes in beneficial ownershipNov 3, 2026
4Statement of changes in beneficial ownershipNov 3, 2026

How much revenue does ASMB generate?

Assembly Biosciences, Inc. (ASMB) reported $72.30M of revenue in fiscal 2025.

Is ASMB profitable?

Assembly Biosciences, Inc. (ASMB) reported -$6.12M of net income, with a net margin of -8.5%.